US 7411067
Crystalline forms of gatifloxacin
granted A61PA61P31/04
Quick answer
US patent 7411067 (Crystalline forms of gatifloxacin) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P31/04